Review




Structured Review

Autobio Diagnostics anti-hbs elisa kit
Anti Hbs Elisa Kit, supplied by Autobio Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-hbs elisa kit/product/Autobio Diagnostics
Average 90 stars, based on 1 article reviews
anti-hbs elisa kit - by Bioz Stars, 2026-02
90/100 stars

Images



Similar Products

94
Bio-Rad anti hbs antibody elisa kit
Progressive reduction in serum HBsAg detected with <t>ELISA</t> was corroborated with western blot results and supported by intracellular HBsAg reduction (A) Progressive reduction of serum HBsAg detected by ELISA in mouse 838 (A1 orange) who received a single dose of HBVZ10 combined with 12-week ETV and was corroborated by western blot (A2). Mouse 831 was a mock-treated control. 100 × Hep: Positive control with concentrated viral particles from the HepAD38 cell medium. (B) Progressive reduction of serum HBsAg detected by ELISA in mouse 970 (B1 orange) who received mouse anti-HBs antibody monotherapy at a dose of 250 μg/injection triweekly for 9 consecutive times and was corroborated by western blot (B2). Mouse 907 was a mock-treated control. ADR and ADW: HBV positive human sera. 100xHepAD, Positive control with concentrated viral particles from HepAD38 cell medium. 35526 and 34477, negative human sera. X, no sample lane. Intrahepatic HBsAg was undetectable by ELISA (C1) in lysates (30 μL each) from seven mice that achieved an HBsAg − /anti-HBs + serum status. Consistently, western blot analysis (C2) of 40 μL liver lysates showed either undetectable or markedly reduced HBsAg levels in these seven mice compared with three untreated controls (mice 907, 987, and 471). (D) Intrahepatic HBc protein analyzed using western blot. 100xHepAD, Positive control with concentrated viral particles from HepAD38 cell medium. 100× GFP-HepG2 cell lysate, negative control. BHK-020, Uninfected liver lysate as negative control. X, no sample lane. Mice 812, 813, 814, 824, and 838 in green were the five mice with progressive reduction of serum HBsAg level upon blocking cccDNA replenishment. Mice 831 and 805 in blue were mock treated. Mouse 833 in purple received a single dose of HBVZ10 monotherapy on day 44pi. Four liver lysates from each liver were analyzed, and numbered as 1, 2, 3, and 4 or 5, 6, 7, and 8 or 11, 12, 13, and 14, respectively after mouse ID number.
Anti Hbs Antibody Elisa Kit, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti hbs antibody elisa kit/product/Bio-Rad
Average 94 stars, based on 1 article reviews
anti hbs antibody elisa kit - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

94
Bio-Rad anti hbs antibody elisa kit 578
Progressive reduction in serum HBsAg detected with <t>ELISA</t> was corroborated with western blot results and supported by intracellular HBsAg reduction (A) Progressive reduction of serum HBsAg detected by ELISA in mouse 838 (A1 orange) who received a single dose of HBVZ10 combined with 12-week ETV and was corroborated by western blot (A2). Mouse 831 was a mock-treated control. 100 × Hep: Positive control with concentrated viral particles from the HepAD38 cell medium. (B) Progressive reduction of serum HBsAg detected by ELISA in mouse 970 (B1 orange) who received mouse anti-HBs antibody monotherapy at a dose of 250 μg/injection triweekly for 9 consecutive times and was corroborated by western blot (B2). Mouse 907 was a mock-treated control. ADR and ADW: HBV positive human sera. 100xHepAD, Positive control with concentrated viral particles from HepAD38 cell medium. 35526 and 34477, negative human sera. X, no sample lane. Intrahepatic HBsAg was undetectable by ELISA (C1) in lysates (30 μL each) from seven mice that achieved an HBsAg − /anti-HBs + serum status. Consistently, western blot analysis (C2) of 40 μL liver lysates showed either undetectable or markedly reduced HBsAg levels in these seven mice compared with three untreated controls (mice 907, 987, and 471). (D) Intrahepatic HBc protein analyzed using western blot. 100xHepAD, Positive control with concentrated viral particles from HepAD38 cell medium. 100× GFP-HepG2 cell lysate, negative control. BHK-020, Uninfected liver lysate as negative control. X, no sample lane. Mice 812, 813, 814, 824, and 838 in green were the five mice with progressive reduction of serum HBsAg level upon blocking cccDNA replenishment. Mice 831 and 805 in blue were mock treated. Mouse 833 in purple received a single dose of HBVZ10 monotherapy on day 44pi. Four liver lysates from each liver were analyzed, and numbered as 1, 2, 3, and 4 or 5, 6, 7, and 8 or 11, 12, 13, and 14, respectively after mouse ID number.
Anti Hbs Antibody Elisa Kit 578, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti hbs antibody elisa kit 578/product/Bio-Rad
Average 94 stars, based on 1 article reviews
anti hbs antibody elisa kit 578 - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

90
Abbott Laboratories elisa kits for hbsag, anti-hbs, and anti-hbc
Progressive reduction in serum HBsAg detected with <t>ELISA</t> was corroborated with western blot results and supported by intracellular HBsAg reduction (A) Progressive reduction of serum HBsAg detected by ELISA in mouse 838 (A1 orange) who received a single dose of HBVZ10 combined with 12-week ETV and was corroborated by western blot (A2). Mouse 831 was a mock-treated control. 100 × Hep: Positive control with concentrated viral particles from the HepAD38 cell medium. (B) Progressive reduction of serum HBsAg detected by ELISA in mouse 970 (B1 orange) who received mouse anti-HBs antibody monotherapy at a dose of 250 μg/injection triweekly for 9 consecutive times and was corroborated by western blot (B2). Mouse 907 was a mock-treated control. ADR and ADW: HBV positive human sera. 100xHepAD, Positive control with concentrated viral particles from HepAD38 cell medium. 35526 and 34477, negative human sera. X, no sample lane. Intrahepatic HBsAg was undetectable by ELISA (C1) in lysates (30 μL each) from seven mice that achieved an HBsAg − /anti-HBs + serum status. Consistently, western blot analysis (C2) of 40 μL liver lysates showed either undetectable or markedly reduced HBsAg levels in these seven mice compared with three untreated controls (mice 907, 987, and 471). (D) Intrahepatic HBc protein analyzed using western blot. 100xHepAD, Positive control with concentrated viral particles from HepAD38 cell medium. 100× GFP-HepG2 cell lysate, negative control. BHK-020, Uninfected liver lysate as negative control. X, no sample lane. Mice 812, 813, 814, 824, and 838 in green were the five mice with progressive reduction of serum HBsAg level upon blocking cccDNA replenishment. Mice 831 and 805 in blue were mock treated. Mouse 833 in purple received a single dose of HBVZ10 monotherapy on day 44pi. Four liver lysates from each liver were analyzed, and numbered as 1, 2, 3, and 4 or 5, 6, 7, and 8 or 11, 12, 13, and 14, respectively after mouse ID number.
Elisa Kits For Hbsag, Anti Hbs, And Anti Hbc, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/elisa kits for hbsag, anti-hbs, and anti-hbc/product/Abbott Laboratories
Average 90 stars, based on 1 article reviews
elisa kits for hbsag, anti-hbs, and anti-hbc - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

94
Bio-Rad monolisatm anti hbs plus elisa kit
Progressive reduction in serum HBsAg detected with <t>ELISA</t> was corroborated with western blot results and supported by intracellular HBsAg reduction (A) Progressive reduction of serum HBsAg detected by ELISA in mouse 838 (A1 orange) who received a single dose of HBVZ10 combined with 12-week ETV and was corroborated by western blot (A2). Mouse 831 was a mock-treated control. 100 × Hep: Positive control with concentrated viral particles from the HepAD38 cell medium. (B) Progressive reduction of serum HBsAg detected by ELISA in mouse 970 (B1 orange) who received mouse anti-HBs antibody monotherapy at a dose of 250 μg/injection triweekly for 9 consecutive times and was corroborated by western blot (B2). Mouse 907 was a mock-treated control. ADR and ADW: HBV positive human sera. 100xHepAD, Positive control with concentrated viral particles from HepAD38 cell medium. 35526 and 34477, negative human sera. X, no sample lane. Intrahepatic HBsAg was undetectable by ELISA (C1) in lysates (30 μL each) from seven mice that achieved an HBsAg − /anti-HBs + serum status. Consistently, western blot analysis (C2) of 40 μL liver lysates showed either undetectable or markedly reduced HBsAg levels in these seven mice compared with three untreated controls (mice 907, 987, and 471). (D) Intrahepatic HBc protein analyzed using western blot. 100xHepAD, Positive control with concentrated viral particles from HepAD38 cell medium. 100× GFP-HepG2 cell lysate, negative control. BHK-020, Uninfected liver lysate as negative control. X, no sample lane. Mice 812, 813, 814, 824, and 838 in green were the five mice with progressive reduction of serum HBsAg level upon blocking cccDNA replenishment. Mice 831 and 805 in blue were mock treated. Mouse 833 in purple received a single dose of HBVZ10 monotherapy on day 44pi. Four liver lysates from each liver were analyzed, and numbered as 1, 2, 3, and 4 or 5, 6, 7, and 8 or 11, 12, 13, and 14, respectively after mouse ID number.
Monolisatm Anti Hbs Plus Elisa Kit, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monolisatm anti hbs plus elisa kit/product/Bio-Rad
Average 94 stars, based on 1 article reviews
monolisatm anti hbs plus elisa kit - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

90
Autobio Diagnostics anti-hbs elisa kit
Progressive reduction in serum HBsAg detected with <t>ELISA</t> was corroborated with western blot results and supported by intracellular HBsAg reduction (A) Progressive reduction of serum HBsAg detected by ELISA in mouse 838 (A1 orange) who received a single dose of HBVZ10 combined with 12-week ETV and was corroborated by western blot (A2). Mouse 831 was a mock-treated control. 100 × Hep: Positive control with concentrated viral particles from the HepAD38 cell medium. (B) Progressive reduction of serum HBsAg detected by ELISA in mouse 970 (B1 orange) who received mouse anti-HBs antibody monotherapy at a dose of 250 μg/injection triweekly for 9 consecutive times and was corroborated by western blot (B2). Mouse 907 was a mock-treated control. ADR and ADW: HBV positive human sera. 100xHepAD, Positive control with concentrated viral particles from HepAD38 cell medium. 35526 and 34477, negative human sera. X, no sample lane. Intrahepatic HBsAg was undetectable by ELISA (C1) in lysates (30 μL each) from seven mice that achieved an HBsAg − /anti-HBs + serum status. Consistently, western blot analysis (C2) of 40 μL liver lysates showed either undetectable or markedly reduced HBsAg levels in these seven mice compared with three untreated controls (mice 907, 987, and 471). (D) Intrahepatic HBc protein analyzed using western blot. 100xHepAD, Positive control with concentrated viral particles from HepAD38 cell medium. 100× GFP-HepG2 cell lysate, negative control. BHK-020, Uninfected liver lysate as negative control. X, no sample lane. Mice 812, 813, 814, 824, and 838 in green were the five mice with progressive reduction of serum HBsAg level upon blocking cccDNA replenishment. Mice 831 and 805 in blue were mock treated. Mouse 833 in purple received a single dose of HBVZ10 monotherapy on day 44pi. Four liver lysates from each liver were analyzed, and numbered as 1, 2, 3, and 4 or 5, 6, 7, and 8 or 11, 12, 13, and 14, respectively after mouse ID number.
Anti Hbs Elisa Kit, supplied by Autobio Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-hbs elisa kit/product/Autobio Diagnostics
Average 90 stars, based on 1 article reviews
anti-hbs elisa kit - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Pishtaz Teb elisa test anti-hbs elisa kit
Progressive reduction in serum HBsAg detected with <t>ELISA</t> was corroborated with western blot results and supported by intracellular HBsAg reduction (A) Progressive reduction of serum HBsAg detected by ELISA in mouse 838 (A1 orange) who received a single dose of HBVZ10 combined with 12-week ETV and was corroborated by western blot (A2). Mouse 831 was a mock-treated control. 100 × Hep: Positive control with concentrated viral particles from the HepAD38 cell medium. (B) Progressive reduction of serum HBsAg detected by ELISA in mouse 970 (B1 orange) who received mouse anti-HBs antibody monotherapy at a dose of 250 μg/injection triweekly for 9 consecutive times and was corroborated by western blot (B2). Mouse 907 was a mock-treated control. ADR and ADW: HBV positive human sera. 100xHepAD, Positive control with concentrated viral particles from HepAD38 cell medium. 35526 and 34477, negative human sera. X, no sample lane. Intrahepatic HBsAg was undetectable by ELISA (C1) in lysates (30 μL each) from seven mice that achieved an HBsAg − /anti-HBs + serum status. Consistently, western blot analysis (C2) of 40 μL liver lysates showed either undetectable or markedly reduced HBsAg levels in these seven mice compared with three untreated controls (mice 907, 987, and 471). (D) Intrahepatic HBc protein analyzed using western blot. 100xHepAD, Positive control with concentrated viral particles from HepAD38 cell medium. 100× GFP-HepG2 cell lysate, negative control. BHK-020, Uninfected liver lysate as negative control. X, no sample lane. Mice 812, 813, 814, 824, and 838 in green were the five mice with progressive reduction of serum HBsAg level upon blocking cccDNA replenishment. Mice 831 and 805 in blue were mock treated. Mouse 833 in purple received a single dose of HBVZ10 monotherapy on day 44pi. Four liver lysates from each liver were analyzed, and numbered as 1, 2, 3, and 4 or 5, 6, 7, and 8 or 11, 12, 13, and 14, respectively after mouse ID number.
Elisa Test Anti Hbs Elisa Kit, supplied by Pishtaz Teb, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/elisa test anti-hbs elisa kit/product/Pishtaz Teb
Average 90 stars, based on 1 article reviews
elisa test anti-hbs elisa kit - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Abbott Laboratories anti-hbs elisa kit reagent
Progressive reduction in serum HBsAg detected with <t>ELISA</t> was corroborated with western blot results and supported by intracellular HBsAg reduction (A) Progressive reduction of serum HBsAg detected by ELISA in mouse 838 (A1 orange) who received a single dose of HBVZ10 combined with 12-week ETV and was corroborated by western blot (A2). Mouse 831 was a mock-treated control. 100 × Hep: Positive control with concentrated viral particles from the HepAD38 cell medium. (B) Progressive reduction of serum HBsAg detected by ELISA in mouse 970 (B1 orange) who received mouse anti-HBs antibody monotherapy at a dose of 250 μg/injection triweekly for 9 consecutive times and was corroborated by western blot (B2). Mouse 907 was a mock-treated control. ADR and ADW: HBV positive human sera. 100xHepAD, Positive control with concentrated viral particles from HepAD38 cell medium. 35526 and 34477, negative human sera. X, no sample lane. Intrahepatic HBsAg was undetectable by ELISA (C1) in lysates (30 μL each) from seven mice that achieved an HBsAg − /anti-HBs + serum status. Consistently, western blot analysis (C2) of 40 μL liver lysates showed either undetectable or markedly reduced HBsAg levels in these seven mice compared with three untreated controls (mice 907, 987, and 471). (D) Intrahepatic HBc protein analyzed using western blot. 100xHepAD, Positive control with concentrated viral particles from HepAD38 cell medium. 100× GFP-HepG2 cell lysate, negative control. BHK-020, Uninfected liver lysate as negative control. X, no sample lane. Mice 812, 813, 814, 824, and 838 in green were the five mice with progressive reduction of serum HBsAg level upon blocking cccDNA replenishment. Mice 831 and 805 in blue were mock treated. Mouse 833 in purple received a single dose of HBVZ10 monotherapy on day 44pi. Four liver lysates from each liver were analyzed, and numbered as 1, 2, 3, and 4 or 5, 6, 7, and 8 or 11, 12, 13, and 14, respectively after mouse ID number.
Anti Hbs Elisa Kit Reagent, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-hbs elisa kit reagent/product/Abbott Laboratories
Average 90 stars, based on 1 article reviews
anti-hbs elisa kit reagent - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

94
Bio-Rad monolisa hbsag elisa kit
Progressive reduction in serum HBsAg detected with <t>ELISA</t> was corroborated with western blot results and supported by intracellular HBsAg reduction (A) Progressive reduction of serum HBsAg detected by ELISA in mouse 838 (A1 orange) who received a single dose of HBVZ10 combined with 12-week ETV and was corroborated by western blot (A2). Mouse 831 was a mock-treated control. 100 × Hep: Positive control with concentrated viral particles from the HepAD38 cell medium. (B) Progressive reduction of serum HBsAg detected by ELISA in mouse 970 (B1 orange) who received mouse anti-HBs antibody monotherapy at a dose of 250 μg/injection triweekly for 9 consecutive times and was corroborated by western blot (B2). Mouse 907 was a mock-treated control. ADR and ADW: HBV positive human sera. 100xHepAD, Positive control with concentrated viral particles from HepAD38 cell medium. 35526 and 34477, negative human sera. X, no sample lane. Intrahepatic HBsAg was undetectable by ELISA (C1) in lysates (30 μL each) from seven mice that achieved an HBsAg − /anti-HBs + serum status. Consistently, western blot analysis (C2) of 40 μL liver lysates showed either undetectable or markedly reduced HBsAg levels in these seven mice compared with three untreated controls (mice 907, 987, and 471). (D) Intrahepatic HBc protein analyzed using western blot. 100xHepAD, Positive control with concentrated viral particles from HepAD38 cell medium. 100× GFP-HepG2 cell lysate, negative control. BHK-020, Uninfected liver lysate as negative control. X, no sample lane. Mice 812, 813, 814, 824, and 838 in green were the five mice with progressive reduction of serum HBsAg level upon blocking cccDNA replenishment. Mice 831 and 805 in blue were mock treated. Mouse 833 in purple received a single dose of HBVZ10 monotherapy on day 44pi. Four liver lysates from each liver were analyzed, and numbered as 1, 2, 3, and 4 or 5, 6, 7, and 8 or 11, 12, 13, and 14, respectively after mouse ID number.
Monolisa Hbsag Elisa Kit, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monolisa hbsag elisa kit/product/Bio-Rad
Average 94 stars, based on 1 article reviews
monolisa hbsag elisa kit - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

Image Search Results


Progressive reduction in serum HBsAg detected with ELISA was corroborated with western blot results and supported by intracellular HBsAg reduction (A) Progressive reduction of serum HBsAg detected by ELISA in mouse 838 (A1 orange) who received a single dose of HBVZ10 combined with 12-week ETV and was corroborated by western blot (A2). Mouse 831 was a mock-treated control. 100 × Hep: Positive control with concentrated viral particles from the HepAD38 cell medium. (B) Progressive reduction of serum HBsAg detected by ELISA in mouse 970 (B1 orange) who received mouse anti-HBs antibody monotherapy at a dose of 250 μg/injection triweekly for 9 consecutive times and was corroborated by western blot (B2). Mouse 907 was a mock-treated control. ADR and ADW: HBV positive human sera. 100xHepAD, Positive control with concentrated viral particles from HepAD38 cell medium. 35526 and 34477, negative human sera. X, no sample lane. Intrahepatic HBsAg was undetectable by ELISA (C1) in lysates (30 μL each) from seven mice that achieved an HBsAg − /anti-HBs + serum status. Consistently, western blot analysis (C2) of 40 μL liver lysates showed either undetectable or markedly reduced HBsAg levels in these seven mice compared with three untreated controls (mice 907, 987, and 471). (D) Intrahepatic HBc protein analyzed using western blot. 100xHepAD, Positive control with concentrated viral particles from HepAD38 cell medium. 100× GFP-HepG2 cell lysate, negative control. BHK-020, Uninfected liver lysate as negative control. X, no sample lane. Mice 812, 813, 814, 824, and 838 in green were the five mice with progressive reduction of serum HBsAg level upon blocking cccDNA replenishment. Mice 831 and 805 in blue were mock treated. Mouse 833 in purple received a single dose of HBVZ10 monotherapy on day 44pi. Four liver lysates from each liver were analyzed, and numbered as 1, 2, 3, and 4 or 5, 6, 7, and 8 or 11, 12, 13, and 14, respectively after mouse ID number.

Journal: Molecular Therapy. Methods & Clinical Development

Article Title: HBVZ10, an AAV8 vector-based new HBV therapy candidate for cccDNA elimination

doi: 10.1016/j.omtm.2025.101646

Figure Lengend Snippet: Progressive reduction in serum HBsAg detected with ELISA was corroborated with western blot results and supported by intracellular HBsAg reduction (A) Progressive reduction of serum HBsAg detected by ELISA in mouse 838 (A1 orange) who received a single dose of HBVZ10 combined with 12-week ETV and was corroborated by western blot (A2). Mouse 831 was a mock-treated control. 100 × Hep: Positive control with concentrated viral particles from the HepAD38 cell medium. (B) Progressive reduction of serum HBsAg detected by ELISA in mouse 970 (B1 orange) who received mouse anti-HBs antibody monotherapy at a dose of 250 μg/injection triweekly for 9 consecutive times and was corroborated by western blot (B2). Mouse 907 was a mock-treated control. ADR and ADW: HBV positive human sera. 100xHepAD, Positive control with concentrated viral particles from HepAD38 cell medium. 35526 and 34477, negative human sera. X, no sample lane. Intrahepatic HBsAg was undetectable by ELISA (C1) in lysates (30 μL each) from seven mice that achieved an HBsAg − /anti-HBs + serum status. Consistently, western blot analysis (C2) of 40 μL liver lysates showed either undetectable or markedly reduced HBsAg levels in these seven mice compared with three untreated controls (mice 907, 987, and 471). (D) Intrahepatic HBc protein analyzed using western blot. 100xHepAD, Positive control with concentrated viral particles from HepAD38 cell medium. 100× GFP-HepG2 cell lysate, negative control. BHK-020, Uninfected liver lysate as negative control. X, no sample lane. Mice 812, 813, 814, 824, and 838 in green were the five mice with progressive reduction of serum HBsAg level upon blocking cccDNA replenishment. Mice 831 and 805 in blue were mock treated. Mouse 833 in purple received a single dose of HBVZ10 monotherapy on day 44pi. Four liver lysates from each liver were analyzed, and numbered as 1, 2, 3, and 4 or 5, 6, 7, and 8 or 11, 12, 13, and 14, respectively after mouse ID number.

Article Snippet: Serum anti-HBs antibody levels were quantified using the anti-HBs antibody ELISA kit (MONOLISA Anti-HBs EIA, cat. no. 25220, Bio-Rad) with corresponding calibrators (cat. no. 25219, Bio-Rad), following the manufacturer’s instructions.

Techniques: Enzyme-linked Immunosorbent Assay, Western Blot, Control, Positive Control, Injection, Negative Control, Blocking Assay